News & Updates

Does obesity raise risk of hospitalization IBD patients?

27 Oct 2022

Obesity does not increase the likelihood of hospitalization among biologic-treated patients with inflammatory bowel disease (IBD), suggests a recent study.

Does obesity raise risk of hospitalization IBD patients?

27 Oct 2022

Exercise improves quality of life of patients with advanced liver disease

27 Oct 2022

Exercise interventions may result in positive outcomes on muscular or cardiorespiratory fitness and quality of life in patients with advanced liver disease, suggest the results of a systematic review.

Exercise improves quality of life of patients with advanced liver disease

27 Oct 2022

Metformin not protective against older-onset IBD

26 Oct 2022

The use of metformin does not appear to confer any benefits in terms of reducing the risk of older-onset inflammatory bowel disease (IBD), a study has found.

Metformin not protective against older-onset IBD

26 Oct 2022

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists

25 Oct 2022

The use of vedolizumab in the treatment of older patients with inflammatory bowel disease (IBD) appears to not only pose a higher risk of treatment failure but also offer no significant safety advantage when compared with tumour necrosis factor (TNF) antagonists, according to a study.

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists

25 Oct 2022

Early surgery cuts reoperation risk, immunomodulator exposure in Crohn’s disease

22 Oct 2022

Patients with Crohn’s disease (CD) who undergo resection within 29 days of diagnosis are less likely to need reoperation in the future and have lower levels of immunomodulator exposure, a recent study has found.

Early surgery cuts reoperation risk, immunomodulator exposure in Crohn’s disease

22 Oct 2022

Food processing implicated in Crohn’s disease risk

22 Oct 2022

Individuals who consume high amounts of unprocessed or minimally processed foods are less likely to develop Crohn’s disease (CD), according to a study.

Food processing implicated in Crohn’s disease risk

22 Oct 2022

Food insecurity prevents gluten-free diet adoption in coeliac disease patients

22 Oct 2022

One in six patients with coeliac disease (CD) do not have a reliable access to a sufficient amount of affordable and nutrition food, a US study has found. This food insecurity negatively affects the adoption of a gluten-free diet (GFD) and the ability to meet recommended daily intake of most micronutrients.

Food insecurity prevents gluten-free diet adoption in coeliac disease patients

22 Oct 2022

MELD-Na predicts 6-month mortality in decompensated cirrhosis patients

21 Oct 2022

A score of 28 in the Model of End-stage Liver Disease—Sodium (MELD-Na), an objective measure to identify patients with decompensated cirrhosis who are at increased risk of 6-month mortality in time-constrained settings, may prompt talks about hospice to improve value-based healthcare in these individuals, suggests a recent study.

MELD-Na predicts 6-month mortality in decompensated cirrhosis patients

21 Oct 2022

Tofacitinib effective in ulcerative colitis, but higher doses lead to adverse events

21 Oct 2022

The overall efficacy and safety of tofacitinib in moderate-to-severe ulcerative colitis (UC) agree with clinical trial data, but a dose-dependent increase in adverse events (AEs) occurs, which underscores the importance of early dose de-escalation, according to a study.

Tofacitinib effective in ulcerative colitis, but higher doses lead to adverse events

21 Oct 2022

Potassium competitive acid blockers go toe-to-toe with PPI in gastric acid diseases

21 Oct 2022 by

Vonoprazan, a potassium competitive acid blocker (PCAB), is better than proton pump inhibitors (PPI) for the treatment of Helicobacter pylori and erosive oesophagitis, according to a new meta-analysis.

Potassium competitive acid blockers go toe-to-toe with PPI in gastric acid diseases

21 Oct 2022

News & Updates

Filter by Specialty:

Specialty:

Does obesity raise risk of hospitalization IBD patients?

Does obesity raise risk of hospitalization IBD patients?

Exercise improves quality of life of patients with advanced liver disease

Exercise improves quality of life of patients with advanced liver disease

Metformin not protective against older-onset IBD

Metformin not protective against older-onset IBD

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists

Treatment failure risk in older IBD patients higher with vedolizumab vs TNF antagonists

Early surgery cuts reoperation risk, immunomodulator exposure in Crohn’s disease

Early surgery cuts reoperation risk, immunomodulator exposure in Crohn’s disease

Food processing implicated in Crohn’s disease risk

Food processing implicated in Crohn’s disease risk

Food insecurity prevents gluten-free diet adoption in coeliac disease patients

Food insecurity prevents gluten-free diet adoption in coeliac disease patients

MELD-Na predicts 6-month mortality in decompensated cirrhosis patients

MELD-Na predicts 6-month mortality in decompensated cirrhosis patients

Tofacitinib effective in ulcerative colitis, but higher doses lead to adverse events

Tofacitinib effective in ulcerative colitis, but higher doses lead to adverse events

Potassium competitive acid blockers go toe-to-toe with PPI in gastric acid diseases

Potassium competitive acid blockers go toe-to-toe with PPI in gastric acid diseases